Founded in 2012, the Vaccine Development Center of San Antonio (VDCOSA) promotes collaboration among four participating research institutions in infectious disease research and vaccine development in order to facilitate new discoveries and eliminate duplication of resources. UT Health San Antonio, the University of Texas at San Antonio (UTSA), the Southwest Research Institute (SwRI) and the Texas Biomedical Research Institute (Texas Biomed) have established a three-fold mission for VDCOSA: (1) funding pilot projects; (2) hosting an annual conference on infection, immunity and vaccines; and (3) promoting the use of vaccines to enhance public health in San Antonio and the region.
VDCOSA addresses the needs of the military as well as civilian populations and conducts and coordinates research and education programs relating to global and regional health problems.
VDCOSA is a virtual center, utilizing the human and laboratory assets of its participating institutions. In this way, dollars invested in VDCOSA programs through grants or charitable support cover the direct costs of mission-oriented initiatives.
Click here to view a list of past VDCOSA conference keynote speakers.
Wang, H., M. Li, C.-Y. Hung, M Sinha, L Lee, D. Wiesner, V. LeBert, T. Lerksuthirat, K. Galles, M. Suresh, A. DeFranco, C. Lowell, B. Klein and M. Wüthrich. 2016. MyD88 shapes vaccine immunity by extrinsically regulating survival of CD4+ T cells during the contraction phase. PLoS Pathogens. In press.
Hung, C.-Y., Castro-Lopez, N., and Cole, G.T. 2016. Card9- and MyD88-mediated IFN-γ and nitric oxide production is essential for resistance to subcutaneous Coccidioides posadasii infection. Infect. Immun., 84:906-916, Selected for Spotlight, p876. PMCID: PMC4807486.